Is Mjna a good stock to buy? In addition to scoring higher than 11 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, MJNA's 4 overall rating means the stock scores better than 4 percent of all stocks. MJNA has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on MJNA!
Is Mjna an OTC stock?
Looking for a big move from this one soon. This stock is pretty much looked at as the otc ETF for the marijuana sector. (OTC Pink Sheets; MJNA) is the first publicly held company vested in the cannabis and industrial hemp space in America.
Does Mjna pay dividends?
MJNA does not currently pay a dividend.
What is the forecast for Mjna stock?
During the day the stock fluctuated 5.85% from a day low at $0.0205 to a day high of $0.0217.
Predicted Opening Price for Medical Marijuana Inc. of Wednesday, December 8, 2021.
|Fair opening price December 8, 2021||Current price|
Who owns Mjna?
Largest shareholders include MAI Capital Management, Bennicas & Associates, Inc., Oarsman Capital, Inc., Motley Fool Wealth Management, LLC, Smith Chas P & Associates Pa Cpas, Almanack Investment Partners, LLC., Captrust Financial Advisors, Cornercap Investment Counsel Inc, Ancora Advisors, LLC, and Clear Perspectives
Related investments for Is Mjna A Good Stock To Buy?
Where is Mjna located?
Medical Marijuana was founded in March 2009 and is headquartered in Poway, CA.
Is Mjna stock on Robinhood?
Shares of MJNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many shares does Mjna have?
|Avg Vol (3 month) 3||9.33M|
|Shares Outstanding 5||3.44B|
|Implied Shares Outstanding 6||N/A|
|% Held by Insiders 1||0.00%|
Is Mjna a pink stock?
Medical Marijuana Inc (OTC Pink - Current Information:MJNA)
engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. It operates through the following three segments: U.S. Operations, HempMeds and Kannaway.
Who is Stuart Titus?
Dr. Stuart Titus began his career on Wall Street with CS First Boston, where he worked as a bond trader and underwriter for 11 years. During his career as a Physiotherapist, he earned a PhD degree from the Open International University which is a World Health Organization (WHO) chartered affiliate.
Is Pharmacann a public company?
Reuters noted that Pharmacann Rival AWH Holdings Inc. also recently went public. Since its May listing, the shares have risen by 38 percent to result in a $1.9 billion valuation. Legal marijuana sales in the U.S. could reach $45 billion by 2025, said JMP Securities analysts.
Is Mjna an American company?
San Diego, California, U.S. Medical Marijuana, Inc. (traded over the counter as MJNA), is a holding company with subsidiaries that make and sell a range of hemp-based products.
Is Mjna profitable?
Accelerating Growth: MJNA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average. Earnings vs Industry: MJNA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (26.7%).
Is Cresco labs on Robinhood?
You Can't Buy Cresco Labs on Robinhood (You're Missing Out) Even though Canada has fully legalized recreational cannabis, the market is much smaller than the United States.
Is MJNA a shell company?
MJNA was, for all intents and purposes, a shell corporation with a catchy ticker symbol.
Is PharmaCann a good company?
PharmaCann is an amazing company! They are constantly working to improve the customer experience, the quality and availability of the product and to improve the employee culture.
Who owns PharmaCann?
PharmaCann had agreed to be taken over by New York rival MedMen Enterprises Inc in 2018 for around $700 million, but that deal fell apart the following year.
Will PharmaCann go public?
Chicago-based cannabis multistate operator PharmaCann reportedly intends to go public in the fall with an initial stock offering that could be valued at more than $1 billion. PharmaCann is one of 10 medical marijuana operators in New York.